Patent ID: 11939334
Assignee: UPPTHERA, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 10:
11. The method according to claim 10, wherein the benign tumor or the cancer is selected from acute leukemia, adrenal cancer, adrenocorticoid tumor, anal muscle cancer, Barrett's esophagus, bladder cancer, blood cancer, bone cancer, brain cancer, breast cancer, breast cyst, breast fibroadenoma, cervical cancer, cholangiocarcinoma, chronic leukemia, colon adenoma, colon cancer, colon polyp, colorectal cancer, endocrine cancer, endometrial cancer, esophageal cancer, gastric cancer, gastrointestinal cancer, glioblastoma, glioma, head and neck cancer, hepatocellular carcinoma, intraocular melanoma, kidney cancer, large cell lymphoma, liver cancer, liver tumor, lung adenocarcinoma, lymphocytic lymphoma, monoclonal gammopathy of undetermined significance (MGUS), monoclonal lymphocytosis, neuroblastoma, neuroendocrine cancer, neuroendocrine tumor, non-small cell lung cancer, osteosarcoma, ovarian cancer, pancreatic cancer, parathyroid cancer, peritoneal cancer, prostate cancer, rectal cancer, salivary gland cancer, skin cancer, skin melanoma, small cell lung cancer, small intestine cancer, soft tissue sarcoma, solid tumor, a squamous cell carcinoma, t cell leukemia, t cell lymphoma, thyroid cancer, urethral cancer, uterine cancer, or vulvar cancer, or a combination thereof.